Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose...

Descripción completa

Detalles Bibliográficos
Autores principales: Patsatsi, Aikaterini, Kyriakou, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834280/
https://www.ncbi.nlm.nih.gov/pubmed/33972053
http://dx.doi.org/10.1016/j.clindermatol.2020.12.012
_version_ 1783642247418347520
author Patsatsi, Aikaterini
Kyriakou, Aikaterini
author_facet Patsatsi, Aikaterini
Kyriakou, Aikaterini
author_sort Patsatsi, Aikaterini
collection PubMed
description Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose, such as the grade of immunosuppression or immunomodulation, discontinuation or modification of treatment, and initiation of new treatments. In this comprehensive review, we present the current evidence about the course and management of chronic inflammatory dermatoses during the COVID-19 pandemic, focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa.
format Online
Article
Text
id pubmed-7834280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78342802021-01-26 Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence? Patsatsi, Aikaterini Kyriakou, Aikaterini Clin Dermatol Article Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose, such as the grade of immunosuppression or immunomodulation, discontinuation or modification of treatment, and initiation of new treatments. In this comprehensive review, we present the current evidence about the course and management of chronic inflammatory dermatoses during the COVID-19 pandemic, focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa. Elsevier Inc. 2021 2020-12-15 /pmc/articles/PMC7834280/ /pubmed/33972053 http://dx.doi.org/10.1016/j.clindermatol.2020.12.012 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Patsatsi, Aikaterini
Kyriakou, Aikaterini
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title_full Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title_fullStr Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title_full_unstemmed Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title_short Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
title_sort impact of the covid-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: what's the evidence?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834280/
https://www.ncbi.nlm.nih.gov/pubmed/33972053
http://dx.doi.org/10.1016/j.clindermatol.2020.12.012
work_keys_str_mv AT patsatsiaikaterini impactofthecovid19pandemiconthecourseandmanagementofchronicinflammatoryimmunemediatedskindiseaseswhatstheevidence
AT kyriakouaikaterini impactofthecovid19pandemiconthecourseandmanagementofchronicinflammatoryimmunemediatedskindiseaseswhatstheevidence

Ejemplares similares